Science Advisory Board

Science Advisory Board

RudaCure's Science Advisory Board (SAB) comprises world-class experts in ion channel pharmacology, pain research, ophthalmology, and AI-driven drug discovery, providing strategic guidance for our core pipeline.

Dr. Yong-ho Kim

Dr. Yong-ho Kim

SAB Chair / CEO

Professor, Gachon University College of Medicine

Ion Channel PharmacologyPain ResearchTRPV1

Over 15 years of basic medical research in pain and sensory disorders. Founder of the TRPV1 ion channel modulation-based drug development platform.

DJ

Dr. Jiyoon Shin

Research Director

RudaCure Central Research Institute

AI Drug DiscoveryMolecular SimulationComputational Drug Design

Expert in AI-driven drug development efficiency. Leads core technology development of the RuCIA platform with structure-based molecular design.

Prof. Donghyun Kim

Prof. Donghyun Kim

EVP / Clinical Advisor

Korea University Anam Hospital, Dept. of Ophthalmology

OphthalmologyDry Eye DiseaseCorneal Disorders

Demonstrated RCI001 long-term safety and Sjögren's syndrome efficacy. Recipient of KOES Academic Award and Taejun Best Ophthalmology Paper Award.

Prof. Dohun Kwon

Prof. Dohun Kwon

External Advisor

POSTECH (Pohang University of Science and Technology)

TRPV1 Structural AnalysisProtein Structural BiologyCryo-EM

Expert in TRPV1 ion channel structural analysis. Conducting joint research with RudaCure on TRPV1 structure-activity relationships.

Dr. Anat Galor, MD, MSPH

Dr. Anat Galor, MD, MSPH

External Advisor

Bascom Palmer Eye Institute, University of Miami

Dry Eye DiseaseOcular PainOcular Surface Disease

Professor of Ophthalmology at Bascom Palmer Eye Institute. World-renowned authority on dry eye disease and neuropathic ocular pain. PI on multiple NIH grants, 355+ publications (h-index 51). Named to The Ophthalmologist Power List.

Dr. Victor L. Perez, MD

Dr. Victor L. Perez, MD

External Advisor

Bascom Palmer Eye Institute, University of Miami

Ocular ImmunologyCorneal DiseaseDry Eye Disease

Professor of Ophthalmology and Director of Cornea Research at Bascom Palmer Eye Institute. Led the TFOS DEWS III global dry eye consensus guidelines. Harvard Medical School trained, NIH/CDC research fellow. The Ophthalmologist Power List 2026.

Role of the SAB

1

Scientific validation and strategic guidance for pipeline programs

2

Clinical trial design and regulatory strategy advisory

3

Global academic network connectivity

4

New indication discovery and technology expansion advisory